Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Name
s41467-017-00600-w.pdf
Size
1.45 MB
Format
Adobe PDF
Checksum (MD5)
2c8bdf96b42dc5208c44db5baaa1457e
Author(s)
Grenier, Philippe
Mahmoudi, Morteza
Appel, Eric A.
Lim, Jong-Min
Karnik, Rohit
Farokhzad, Omid C.
Bertrand, Nicolas
Martins Lima, Eliana
Dormont, Flavio
Langer, Robert S
Date Issued
October 2017
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Bertrand, Nicolas et al. “Mechanistic Understanding of in Vivo Protein Corona Formation on Polymeric Nanoparticles and Impact on Pharmacokinetics.” Nature Communications 8, 1 (October 2017): 777 © 2017 The Author(s)
Version
Final published version
Abstract
In vitro incubation of nanomaterials with plasma offer insights on biological interactions, but cannot fully explain the in vivo fate of nanomaterials. Here, we use a library of polymer nanoparticles to show how physicochemical characteristics influence blood circulation and early distribution. For particles with different diameters, surface hydrophilicity appears to mediate early clearance. Densities above a critical value of approximately 20 poly(ethylene glycol) chains (MW 5 kDa) per 100 nm 2 prolong circulation times, irrespective of size. In knockout mice, clearance mechanisms are identified for nanoparticles with low and high steric protection. Studies in animals deficient in the C3 protein showed that complement activation could not explain differences in the clearance of nanoparticles. In nanoparticles with low poly(ethylene glycol) coverage, adsorption of apolipoproteins can prolong circulation times. In parallel, the low-density-lipoprotein receptor plays a predominant role in the clearance of nanoparticles, irrespective of poly(ethylene glycol) density. These results further our understanding of nanopharmacology.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Attribution 4.0 International (CC BY 4.0)
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/S41467-017-00600-W
